The following obituaries have been provided by local funeral homes. Read our complete obituaries in The Herald-Dispatch on Thursday and at www.herald-dispatch.com.
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.
E-Mail
Bentham Science has recently launched the new volume of the book, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series essential for pharmaceutical scientists, postgraduate students and researchers seeking the latest, critical information for developing clinical trials and drafting research plans in anti-cancer research. Reviews in this volume are written by experts in medical oncology and clinical trials research, and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers.
The first chapter covers information on AML (Acute myeloid leukemia). Irrespective of the diverse modes of treatment, the prognosis and clinical response of AML (Acute myeloid leukemia) remain low as the conventional modes of treatment, including cytarabine and anthracycline have their limitations. Additionally, chemotherapy-induced cytotoxicity triggers the